PART I ANI Pharmaceuticals is a diversified bio-pharmaceutical company. The Company's mission is Serving Patients, Improving Lives by developing, manufacturing, and commercializing therapeutics through its Rare Disease, Generics, and Brands businesses. On September 16, 2024, the Company acquired Alimera Sciences, Inc. ("Alimera"). In connection with the acquisition, the Company added two new products, ILUVIEN ("ILUVIEN") and YUTIQ ("YUTIQ"). See Note 3 "Business Combination" in the notes to the ...
Q2 FY2026 — expected 2026-09-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-27 | 2025-12-31 | 0001023024-26-000014 | EDGAR | 98K words |
| 2025-02-28 | 2024-12-31 | 0001023024-25-000015 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001023024-24-000026 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0001023024-23-000005 | EDGAR | — |
| 2022-03-15 | 2021-12-31 | 0001023024-22-000004 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001023024-21-000007 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001104659-20-025744 | EDGAR | — |
| 2019-02-27 | 2018-12-31 | 0001144204-19-010541 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001144204-18-011197 | EDGAR | — |
| 2017-03-02 | 2016-12-31 | 0001144204-17-012507 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001023024-26-000069 | EDGAR | — |
| 2025-11-07 | 2025-09-30 | 0001023024-25-000108 | EDGAR | 39K words |
| 2025-08-08 | 2025-06-30 | 0001023024-25-000082 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0001023024-25-000046 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001023024-24-000102 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001023024-24-000085 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001023024-24-000057 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001023024-23-000043 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001023024-23-000017 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0001023024-23-000010 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001023024-22-000021 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001023024-22-000017 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-07 | 0001023024-26-000068 | EDGAR | — |
| 2026-03-03 | 0001023024-26-000017 | EDGAR | 5K words |
| 2026-02-27 | 0001023024-26-000013 | EDGAR | — |
| 2026-01-12 | 0001023024-26-000005 | EDGAR | — |
| 2025-12-01 | 0001023024-25-000113 | EDGAR | — |
| 2025-11-10 | 0001023024-25-000110 | EDGAR | — |
| 2025-11-07 | 0001023024-25-000107 | EDGAR | — |
| 2025-09-26 | 0001023024-25-000099 | EDGAR | — |
| 2025-09-08 | 0001023024-25-000089 | EDGAR | — |
| 2025-08-08 | 0001023024-25-000081 | EDGAR | — |
273 total filings indexed. 241 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001023024 |
| Ticker | ANIP |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.anipharmaceuticals.com |
| Listed | 1999-09-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ANIP (~200 tokens, structured JSON with cryptographic provenance)